Abstract:BACKGROUND: To date, the use of bone marrow-derived mesenchymal stem cells (MSCs) for the treatment of Parkinson's disease have solely focused on in vivo animal models. Because of the number of influencing factors, it has been difficult to determine a consistent outcome.OBJECTIVE: To establish an injury model in brain slices of substantia nigra and striaturn using 1-methyl-4-phonylpytidinium ion (MPP), and to investigate the effect of MSCs on dopaminergic neurons following MPP+ induced damage.DESIGN, TIME AND SETTING: An in vitro, randomized, controlled, animal experiment using immunohistochemistry was performed at the Laboratory of the Department of Anatomy, Fudan University between January 2004 and December 2006.MATERIALS: Primary MSC cultures were obtained from femurs and tibias of adult Sprague Dawley rats. Organotypic brain slices were isolated from substantia nigra and striaturn of 1-day-old Sprague Dawley rat pups. Monoclonal antibodies for tyrosine hydroxylase (TH, 1:5 000) were from Santa Cruz (USA); goat anti-rabbit IgG antibodies labeled with FITC were from Boster Company (China).METHODS: Organotypic brain slices were cultured for 5 days in whole culture medium supplemented with 50% DMEM, 25% equine serum, and 25% Tyrode's balanced salt solution. The medium was supplemented with 5 mu g/mLAra-C, and the culture was continued for an additional 5 days. The undergrowth of brain slices was discarded at day 10. Eugonic brain slices were cultured with basal media for an additional 7 days. The brain slices were divided into three groups: control, MPP+ exposure, and co-culture. For the MPP+ group, MPP+ (30 mu mol/L) was added to the media at day 17 and brain slices were cultured for 4 days, followed by control media. For the co-culture group, the MPP+ injured brain slices were placed over MSCs in the well and were further cultured for 7 days. MAINOUTCOME MEASURES: After 28 days in culture, neurite outgrowth was examined in the brain slices under phase-contrast microscopy. The percent of area containing dead cells in each brain slice was calculated with the help of propidium iodide fluorescence. Brain slices were stained with antibodies for TH to indicate the presence of dopaminergic neurons. Transmission electron microscopy was applied to determine the effect of MSCs on neuronal ultrastructure.RESULTS: Massive cell death and neurite breakage was observed in the MPP+ group. In addition, TH expression was significantly reduced, compared to the control group (P < 0.01). After 7 days in culture With MSCs, the co-culture group presented with less cell damage and reduced neurite breakage, and TH expression was increased. However, these changes were not significantly different from the MPP+ group (P < 0.01). Electron microscopy revealed reduced ultrastructural injury to cells in the brain slices. However, vacuoles were present in cells, With some autophagic vacuoles.CONCLUSION: Bone marrow-derived MSCs can promote survival of dopaminergic neurons following MPP+-induced neurotoxicity in co-cultures with substantia nigra and striaturn brain slices.

Autologous transplantation of GDNF-expressing mesenchymal stem cells protects against MPTP-induced damage in cynomolgus monkeys

GDNF Promotes Survival and Therapeutic Efficacy of Human Adipose-Derived Mesenchymal Stem Cells in a Mouse Model of Parkinson's Disease

GDNF-secreting mesenchymal stem cells provide localized neuroprotection in an inflammation-driven rat model of Parkinson's disease

Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson's disease

Long-term benefits of hematopoietic stem cell-based macrophage/microglia delivery of GDNF to the CNS in a mouse model of Parkinson's disease

Human neural stem cells promote mitochondrial genesis to alleviate neuronal damage in MPTP-induced cynomolgus monkey models

Protective Effect of Bone Marrow-Derived Mesenchymal Stem Cells on Dopaminergic Neurons Against 1-Methyl-4-phenylpyridinium Ion-Induced Neurotoxicity in Rat Brain Slices

Therapeutic effects of intranigral transplantation of mesenchymal stem cells in rat models of Parkinson's disease

Autologous Ipsc-Derived Dopamine Neuron Transplantation in a Nonhuman Primate Parkinson’s Disease Model

Intravenous mesenchymal stem cell administration exhibits therapeutic effects against 6-hydroxydopamine-induced dopaminergic neurodegeneration and glial activation in rats

Transplantation of Human Neural Stem Cells in a Parkinsonian Model Exerts Neuroprotection Via Regulation of the Host Microenvironment

Mesenchymal stromal SB623 cell implantation mitigates nigrostriatal dopaminergic damage in a mouse model of Parkinson's disease

Intrastriatal Transplantation of GDNF-engineered BMSCs and its neuroprotection in Lactacystin-induced Parkinsonian Rat Model

Observation on intracerebrally transplanted BMSCs-D-NSCs modified by TH and EGFP gene in hemiparkinsonism monkey

Migration and Differentiation of Mesenchymal Stem Cells Labeled with Enhanced Green Fluorescent Protein in the Parkinson's Disease Rat Brain

Combined MSC-Secreted Factors and Neural Stem Cell Transplantation Promote Functional Recovery of PD Rats

Neuroprotetive effect of glial cell line-derived neurotrophic factor gene-modified bone marrow stromal cells transplantation on intracerebral hemorrhage in rats

Long-Term Efficacy and Safety of Human Umbilical Cord Mesenchymal Stromal Cells in Rotenone-Induced Hemiparkinsonian Rats

Mesenchymal stem cell transplantation and DMEM administration in a 3NP rat model of Huntington's disease: morphological and behavioral outcomes

Gene Therapy in Hemiparkinsonian Rhesus Monkeys: Long-Term Survival and Behavioral Recovery by Transplantation of Autologous Human Tyrosine Hydroxylase-Expressing Neural Stem Cells.

Neuroprotective effects of bone marrow stem cells overexpressing glial cell line-derived neurotrophic factor on rats with intracerebral hemorrhage and neurons exposed to hypoxia/reoxygenation.